Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands

Detalles Bibliográficos
Autores principales: Härmark, Linda, Weits, Gerda, Meijer, Rietje, Santoro, Federica, Norén, G. Niklas, van Hunsel, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395902/
https://www.ncbi.nlm.nih.gov/pubmed/32617875
http://dx.doi.org/10.1007/s40264-020-00970-z
_version_ 1783565478832111616
author Härmark, Linda
Weits, Gerda
Meijer, Rietje
Santoro, Federica
Norén, G. Niklas
van Hunsel, Florence
author_facet Härmark, Linda
Weits, Gerda
Meijer, Rietje
Santoro, Federica
Norén, G. Niklas
van Hunsel, Florence
author_sort Härmark, Linda
collection PubMed
description
format Online
Article
Text
id pubmed-7395902
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-73959022020-08-18 Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands Härmark, Linda Weits, Gerda Meijer, Rietje Santoro, Federica Norén, G. Niklas van Hunsel, Florence Drug Saf Correction Springer International Publishing 2020-07-02 2020 /pmc/articles/PMC7395902/ /pubmed/32617875 http://dx.doi.org/10.1007/s40264-020-00970-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Correction
Härmark, Linda
Weits, Gerda
Meijer, Rietje
Santoro, Federica
Norén, G. Niklas
van Hunsel, Florence
Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands
title Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands
title_full Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands
title_fullStr Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands
title_full_unstemmed Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands
title_short Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands
title_sort correction to: communicating adverse drug reaction insights through patient organizations: experiences from a pilot study in the netherlands
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395902/
https://www.ncbi.nlm.nih.gov/pubmed/32617875
http://dx.doi.org/10.1007/s40264-020-00970-z
work_keys_str_mv AT harmarklinda correctiontocommunicatingadversedrugreactioninsightsthroughpatientorganizationsexperiencesfromapilotstudyinthenetherlands
AT weitsgerda correctiontocommunicatingadversedrugreactioninsightsthroughpatientorganizationsexperiencesfromapilotstudyinthenetherlands
AT meijerrietje correctiontocommunicatingadversedrugreactioninsightsthroughpatientorganizationsexperiencesfromapilotstudyinthenetherlands
AT santorofederica correctiontocommunicatingadversedrugreactioninsightsthroughpatientorganizationsexperiencesfromapilotstudyinthenetherlands
AT norengniklas correctiontocommunicatingadversedrugreactioninsightsthroughpatientorganizationsexperiencesfromapilotstudyinthenetherlands
AT vanhunselflorence correctiontocommunicatingadversedrugreactioninsightsthroughpatientorganizationsexperiencesfromapilotstudyinthenetherlands

Ejemplares similares